The provided text is an auditor consent exhibit (EX-23.1) from Niagen Bioscience, Inc.'s Annual Report on Form 10-K, filed with the SEC. It contains consent from Crowe LLP for incorporation of audit reports into registration statements. No business description, products, or services are described in this excerpt.
Q2 FY2026 — expected 2026-08-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-04 | 2025-12-31 | 0001386570-26-000013 | EDGAR | 56K words |
| 2025-03-04 | 2024-12-31 | 0001628280-25-009774 | EDGAR | — |
| 2024-03-06 | 2023-12-31 | 0001628280-24-009380 | EDGAR | — |
| 2023-03-08 | 2022-12-31 | 0001628280-23-006968 | EDGAR | — |
| 2022-03-14 | 2021-12-31 | 0001628280-22-006041 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001654954-21-002692 | EDGAR | — |
| 2020-03-10 | 2019-12-31 | 0001654954-20-002437 | EDGAR | — |
| 2019-03-07 | 2018-12-31 | 0001654954-19-002395 | EDGAR | — |
| 2018-03-15 | 2017-12-30 | 0001654954-18-002621 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001654954-17-002092 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-04 | 2026-06-30 | 0001386570-26-000043 | EDGAR | — |
| 2025-11-04 | 2025-09-30 | 0001386570-25-000020 | EDGAR | 38K words |
| 2025-08-06 | 2025-06-30 | 0001386570-25-000010 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0001628280-25-023127 | EDGAR | — |
| 2024-10-31 | 2024-09-30 | 0001628280-24-044540 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0001628280-24-035591 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001628280-24-021645 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001628280-23-037809 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001628280-23-028551 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001628280-23-017204 | EDGAR | — |
| 2022-11-02 | 2022-09-30 | 0001628280-22-027803 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001628280-22-022216 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-04 | 0001386570-26-000042 | EDGAR | — |
| 2026-03-19 | 0001386570-26-000017 | EDGAR | 1K words |
| 2026-03-04 | 0001386570-26-000014 | EDGAR | — |
| 2026-02-26 | 0001386570-26-000003 | EDGAR | — |
| 2025-12-22 | 0001386570-25-000030 | EDGAR | — |
| 2025-11-06 | 0001386570-25-000025 | EDGAR | — |
| 2025-11-04 | 0001386570-25-000021 | EDGAR | — |
| 2025-10-06 | 0001386570-25-000015 | EDGAR | — |
| 2025-08-06 | 0001386570-25-000011 | EDGAR | — |
| 2025-07-29 | 0001628280-25-036445 | EDGAR | — |
355 total filings indexed. 323 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001386570 |
| Ticker | NAGE |
| Exchange | Nasdaq |
| SIC | 2833: Medicinal Chemicals & Botanical Products |
| Incorporated | DE |
| Headquarters | Costa Mesa, California |
| Website | https://www.niagenbioscience.com |
| Listed | 2008-06-24 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/NAGE (~200 tokens, structured JSON with cryptographic provenance)